G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,540,000 | -22.1% | 474,716 | -50.0% | 0.07% | -18.1% |
| Q3 2020 | $10,966,000 | -52.4% | 949,431 | 0.0% | 0.08% | -60.7% |
| Q2 2020 | $23,033,000 | +120.1% | 949,431 | 0.0% | 0.21% | +49.6% |
| Q1 2020 | $10,463,000 | -58.3% | 949,431 | 0.0% | 0.14% | -55.0% |
| Q4 2019 | $25,093,000 | +16.0% | 949,431 | 0.0% | 0.31% | +5.4% |
| Q3 2019 | $21,628,000 | -25.7% | 949,431 | 0.0% | 0.30% | -54.4% |
| Q2 2019 | $29,110,000 | +84.7% | 949,431 | 0.0% | 0.65% | +48.3% |
| Q1 2019 | $15,761,000 | -13.3% | 949,431 | 0.0% | 0.44% | -41.8% |
| Q4 2018 | $18,182,000 | – | 949,431 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |